Publikasi Scopus Covid-19 Per 14 Agustus 2024 (559 artikel)

Adzdzakiy M.M.; Asyifa I.Z.; Sativa A.R.; Al Fiqri A.R.; Dharmayanthi A.B.; Prasetyoputri A.; Saputra S.
Adzdzakiy, Muhammad Mumtaz (58070801500); Asyifa, Isnaini Zakiyyah (58070801600); Sativa, Alvira Rifdah (58071432300); Al Fiqri, Ahmad Ridha (58071077000); Dharmayanthi, Anik Budhi (57193719895); Prasetyoputri, Anggia (56309877800); Saputra, Sugiyono (57076979100)
58070801500; 58070801600; 58071432300; 58071077000; 57193719895; 56309877800; 57076979100
SARS-CoV-2 Infections in Certain Groups: A Review from COVID-19 Study Cases
2023
AIP Conference Proceedings
2606
030011
0
Graduate Program of Bioscience, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Central Java, Surakarta, 57126, Indonesia; Master Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; School of Life Science and Technology, Bandung Institute of Technology, Jl. Ganesa 10, West Java, Bandung, 40132, Indonesia; Research Center for Biology, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta Bogor Km 46, West Java, Bogor, 16911, Indonesia; Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta Bogor Km 46, West Java, Bogor, 16911, Indonesia
Adzdzakiy M.M., Graduate Program of Bioscience, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Central Java, Surakarta, 57126, Indonesia; Asyifa I.Z., Master Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Sativa A.R., School of Life Science and Technology, Bandung Institute of Technology, Jl. Ganesa 10, West Java, Bandung, 40132, Indonesia; Al Fiqri A.R., Master Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Dharmayanthi A.B., Research Center for Biology, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta Bogor Km 46, West Java, Bogor, 16911, Indonesia; Prasetyoputri A., Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta Bogor Km 46, West Java, Bogor, 16911, Indonesia; Saputra S., Research Center for Biology, National Research and Innovation Agency (BRIN), Jl. Raya Jakarta Bogor Km 46, West Java, Bogor, 16911, Indonesia
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the current pandemic of COVID-19 and is highly infectious with relatively high mortality risk. In this study, we reviewed and summarized miscellaneous COVID-19 cases from vulnerable groups, including children and those with comorbidity, reinfections, coinfections and vaccinated individuals, and rapid transmission cases to understand if there are any specific SARS-CoV-2 variants that infect those groups. We concluded that there were no specific variants associated with higher rates of infection within certain groups, rather, they may tend to infect any groups with any immunity levels, regardless of geographical boundaries. A high prevalence of SARS-CoV-2 infection is mainly driven by the ability of viruses with genetic markers that have been associated with higher risks of transmission and immune escape in vulnerable groups. Disease severity is not only influenced by the virus, but also host conditions such as gender, age, comorbidity, and obesity. The likelihood of new emerging SARS-CoV-2 variants resulting from infections in vulnerable groups is high, thus monitoring viral genetic markers and mutations is crucial for outbreak preparedness. © 2023 American Institute of Physics Inc.. All rights reserved.
American Institute of Physics Inc.
0094243X
978-073544305-1
Conference paper
-